Organigram Global (OGI) Other Non-Current Assets (2023 - 2025)

Organigram Global (OGI) posted quarterly Other Non-Current Assets of $36.0 million for Q3 2025, up 20.59% year-on-year from $29.9 million in Q3 2024, and up 20.59% on a QoQ basis from $29.9 million in Q3 2024.

Organigram Global (OGI) Other Non-Current Assets (2023 - 2025) Analysis & Trends

Organigram Global (OGI) has reported Other Non-Current Assets for 3 consecutive years, with $36.0 million the latest figure, recorded in Q3 2025.

  • Quarterly Other Non-Current Assets rose 20.59% year-over-year to $36.0 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $36.0 million (up 20.59% YoY) and the FY2025 annual result came in at $36.0 million, up 20.59% from the prior year.
  • Other Non-Current Assets rose to $36.0 million in Q3 2025 per OGI's latest filing, from $29.9 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for OGI reached as high as $36.0 million in Q3 2025 and fell as low as $13.3 million in Q3 2023.
  • A 3-year average of $26.4 million and a median of $29.9 million in 2024 frame the typical range for Other Non-Current Assets.
  • Annual changes were most pronounced in 2024 — Other Non-Current Assets surged 123.68% — and 2025, when it increased 20.59%.
  • Year by year, Other Non-Current Assets stood at $13.3 million in 2023, then jumped by 123.68% to $29.9 million in 2024, then advanced by 20.59% to $36.0 million in 2025.
  • According to Business Quant data, Other Non-Current Assets over the past three periods registered $36.0 million, $29.9 million, and $13.3 million for Q3 2025, Q3 2024, and Q3 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Organigram Global 89.89 Mn 122.96 Mn 28.97 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 36.00 Mn
Sep 30, 2024 29.86 Mn
Sep 30, 2023 13.35 Mn